News / Business
Top Drug Stocks Surge in Morning Session (NEXM, SNSS, DARA, VVUS)
Drug Stocks Surge
NexMed, Inc. (NASDAQ:NEXM) soared 36.70% to $0.547 announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco, its cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate. Over the last 52 weeks the stock has ranged from a low of $0.12 to a high of $0.84.
Subscribe to daily free stock newsletter by visiting: http://www.PennyStockPickReport.com
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) zoomed 14.29% to $1.12. Over the last 52 weeks the stock has ranged from a low of $0.17 to a high of $2.43.
DARA BioSciences, Inc. (NASDAQ:DARA) jumped 9.09% to $0.480 after it announced that DARA Therapeutics, a subsidiary of the Company and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Over the last 52 weeks the stock has ranged from a low of $0.23 to a high of $1.00.
VIVUS, Inc. (NASDAQ:VVUS) surged 5.78% to $9.33 Started as Buy at Brean Murray. Over the last 52 weeks the stock has ranged from a low of $3.70 to a high of $12.88. Today IT announced that it will report financial results for the first quarter ended
About http://www.PennyStockPickReport.com
Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.
